ANXA11 and amyotrophic lateral sclerosis: In conclusion, this population-based study from an Italian epidemiological register demonstrates that ANXA11 pathogenic variants account for approximately 1.0% of ALS cases, with all tested individuals exhibiting some degree of cognitive and behavioral impairment.